{"id":25065,"date":"2024-02-16T12:50:44","date_gmt":"2024-02-16T11:50:44","guid":{"rendered":"https:\/\/idibell.cat\/?p=25065"},"modified":"2024-02-16T12:54:26","modified_gmt":"2024-02-16T11:54:26","slug":"se-celebra-la-primera-jornada-dinnovacio-sobre-el-diagnostic-i-tractament-dels-pacients-amb-cancer-de-pulmo-al-campus-de-bellvitge","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2024\/02\/se-celebra-la-primera-jornada-dinnovacio-sobre-el-diagnostic-i-tractament-dels-pacients-amb-cancer-de-pulmo-al-campus-de-bellvitge\/","title":{"rendered":"Se celebra la primera Jornada d\u2019Innovaci\u00f3 sobre el Diagn\u00f2stic i Tractament dels Pacients amb C\u00e0ncer de Pulm\u00f3 al Campus de Bellvitge"},"content":{"rendered":"

L\u2019Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL), conjuntament amb l\u2019Institut Catal\u00e0 d\u2019Oncologia (ICO) i l\u2019Hospital Universitari de Bellvitge (HUB), celebren avui divendres, 16 de febrer, la 1a Jornada d\u2019Innovaci\u00f3 sobre el Diagn\u00f2stic i Tractament dels Pacients amb C\u00e0ncer de Pulm\u00f3. La jornada est\u00e0 impulsada per la Unitat Funcional de Pulm\u00f3 del Campus Bellvitge i reuneix a prop de 100 professionals de les institucions organitzadores, d\u2019hospitals comarcals i de centres d\u2019atenci\u00f3 prim\u00e0ria per compartir i debatre els \u00faltims aven\u00e7os en el camp.<\/p>\n

 <\/p>\n

El congr\u00e9s t\u00e9 lloc a la sala d\u2019actes de l\u2019Hospital Universitari de Bellvitge i est\u00e0 coordinada pel Dr. Ernest Nadal i la Dra. Susana Padrones, investigadors de l\u2019IDIBELL i metges especialistes a l\u2019ICO i l\u2019Hospital de Bellvitge, respectivament. Com a activitat formativa, va dirigida especialment al personal m\u00e8dic implicat en el maneig de pacients amb c\u00e0ncer de pulm\u00f3 de la xarxa d\u2019hospitals de l\u2019\u00c0rea Metropolitana Sud vinculats a l\u2019ICO i l\u2019HUB, aix\u00ed com a altres especialistes amb inter\u00e8s en la patologia.<\/p>\n

 <\/p>\n

Durant el dia es faran una s\u00e8rie de xerrades que s\u2019han organitzat en tres blocs tem\u00e0tics. En el primer bloc sobre diagn\u00f2stic i estudis d\u2019extensi\u00f3 es parlar\u00e0 de circuits assistencials, aven\u00e7os en el diagn\u00f2stic endosc\u00f2pic, i en l\u2019estadificaci\u00f3 no quir\u00fargica, el paper de la infermera i el maneig del n\u00f2dul pulmonar. En el segon bloc, dedicat a la malaltia preco\u00e7, s\u2019abordaran les innovacions en cirurgia tor\u00e0cica i les modalitats de radioter\u00e0pia amb intenci\u00f3 curativa. Finalment, en la tercera i \u00faltima secci\u00f3, centrada en el c\u00e0ncer avan\u00e7at, es revisar\u00e0 l\u2019actualitat en estudis moleculars i seq\u00fcenciaci\u00f3 massiva, medicina de precisi\u00f3 i ter\u00e0pia dirigida, immunoter\u00e0pia i el maneig de l\u2019oligoprogressi\u00f3.<\/p>\n

 <\/p>\n

La Unitat Funcional de Pulm\u00f3, que organitza l\u2019acte, va ser creada el 1998, sent la tercera unitat funcional d\u2019atenci\u00f3 oncol\u00f2gica impulsada per l\u2019ICO i el HUB. Aquestes unitats funcionals coordinen els equips interdisciplinaris especialitzats en cada tipus de c\u00e0ncer per facilitar la determinaci\u00f3 d\u2019un diagn\u00f2stic prec\u00eds i acurat, tractant de proporcionar una atenci\u00f3 \u00f2ptima centrada en els pacients i les seves fam\u00edlies.<\/p>\n

 <\/p>\n

La iniciativa compta amb el recolzament d\u2019MSD, AstraZeneca, Roche, Pfizer, Takeda Pharmaceuticals, Johnson&Johnson i Bristol Myers Squibb.<\/p>\n

 <\/p>\n

 <\/p>\n

L\u2019Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l’Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l’Institut Catal\u00e0 de la Salut, l’Institut Catal\u00e0 d’Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n

L\u2019IDIBELL \u00e9s membre del Campus d’Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L’any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Durant el dia es faran una s\u00e8rie de xerrades organitzades en tres blocs tem\u00e0tics: diagn\u00f2stic i estudis d\u2019extensi\u00f3, tractament de la malaltia preco\u00e7 i del c\u00e0ncer avan\u00e7at.<\/p>\n","protected":false},"author":8,"featured_media":25076,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[332,446,447,333],"tags":[],"class_list":["post-25065","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","category-noticies","category-p-de-mecanismes-molelculars-i-terapia-experimental-en-oncologia-oncobell","category-metabolisme-i-mort-cellular"],"publishpress_future_action":{"enabled":false,"date":"2025-03-01 21:33:17","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25065","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=25065"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25065\/revisions"}],"predecessor-version":[{"id":25066,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25065\/revisions\/25066"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/25076"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=25065"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=25065"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=25065"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}